Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions

Akins, Cary W.; Miller, D. Craig; Turina, Marko; Kouchoukos, Nicholas T.; Blackstone, Eugene H.; Grunkemeier, Gary L.; Takkenberg, Johanna J.M.; David, Tirone E.; Butchart, Eric G.; Adams, David H.; Shahian, David M.; Hagl, S.; Mayer, John E.; Lytle, Bruce W.

doi:10.1016/j.athoracsur.2007.12.082

Cited by 467 publications

(195 citation statements)

References 23 publications

Supporting

Mentioning

187

Contrasting

Unclassified

Order By: Relevance

“…Outcome events were registered according to the 2008 American Association for Thoracic Surgery/Society of Thoracic Surgeons/European Association for Cardiothoracic Surgery guidelines for reporting mortality and morbidity after cardiac valve interventions (12). The EQ instrument is a 5-item general questionnaire assessing five health domains, mobility, self-care, usual activity, pain and discomfort, and anxiety and depression, from which the "EQ index" is then calculated, producing a score from 0 to 1.0, with a higher score indicating best quality of life (13).…”

Section: Methodsmentioning

confidence: 99%

Valve-sparing aortic root replacement—midterm outcomes and quality of life

Bata¹,

D’Ostrevy²,

Pereira³

et al. 2017

Cardiovasc. Diagn. Ther.

View full text Add to dashboard Cite

Background: This study evaluated the midterm outcomes, the valve related events and quality of life of patients treated by valve-sparing aortic root replacement (VSRR). Results: Hospital mortality was 1%. There were 10 late deaths (11%) including 5 cardiac cases. Two patients (2%) required an aortic valve or graft prosthesis reoperation. Aortic valve endocarditis occurred in two patients. Thromboembolic events were reported in three patients. None of the following morbidity has been observed: structural valve deterioration, nonstructural dysfunction, valve thrombosis, bleeding event.The 5-and 8-year survival were 92% and 88%, respectively. The 8-year survival free from cardiac death was 88%. The mean of EuroQoL visual analogue scale (EQ VAS) and EQ index were respectively 83±15 (range 30-100) and 0.94±0.12 (range 0.5-1).Conclusions: Eight-year clinical improvement, function of the spared aortic valve and quality of life after valve sparing aortic root surgery appear excellent.

show abstract

Section: Methodsmentioning

confidence: 99%

Valve-sparing aortic root replacement—midterm outcomes and quality of life

Bata¹,

D’Ostrevy²,

Pereira³

et al. 2017

Cardiovasc. Diagn. Ther.

View full text Add to dashboard Cite

show abstract

“…The STS composite does not include perioperative MI, which is in part due to its low ascertainment reliability. 1 Recommended definitions of perioperative MI vary considerably, from a highly restrictive approach requiring evidence of an acute coronary embolus 57 to a multifaceted approach incorporating clinical and biomarker criteria. 55 Other potentially important cardiac surgery outcomes, such as prolonged postoperative mechanical ventilation, have not been uniformly defined or adopted for use.…”

Section: Discussionmentioning

confidence: 99%

Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal

Goldfarb¹,

Drudi²,

Almohammadi³

et al. 2015

Canadian Journal of Cardiology

View full text Add to dashboard Cite

“…Data acquisition, definition and statistical analyses were accomplished according to the current guidelines for reporting mortality and morbidity after cardiac valve intervention. 8) After patients provided written informed consent, surgery was performed via complete or partial median sternotomy under general anesthesia, normothermic cardiopulmonary bypass and direct aortic clamping using intermittent antegrade warm blood cardioplegia. Mechanical and biological xenograft valve replacements as well as Ross-Procedures were performed.…”

Section: Methodsmentioning

confidence: 99%

Risk and Outcome of Aortic Valve Surgery in the Transcatheter Valve Era: The Gender Aspect

Heinze

Christ

Leonards

et al. 2015

ATCS

View full text Add to dashboard Cite

Results: Women in group II were significantly younger (71.6 ± 9.0 years; p = 0.004) and showed significantly lower risk profiles (logistic EuroSCORE: 9.6 ± 9.9%; p = 0.04) than women in group I (age: 75.6 ± 8.5 years, logistic EuroSCORE: 13.9 ± 15.9). Men's age and risk profiles remained similar in both groups. Observed survival at 30 days was 98.8% in group II and 95.8% in group I which represented a statistical trend (p = 0.09). Female survival in group I was 92.2% and significantly worse as compared to 99% male survival in group I (p = 0.03). This significant difference in gender ratio of mortality was not detected in group II (female survival 97%, male survival 100%; p = 0.2). Being female was a significant risk factor in group I (odds ratio; 8.4; p = 0.03) but not in group II any longer (odds ratio: 1.0; p = 0.2). Conclusions: The possibility of transcatheter aortic valve replacement for therapy of aortic stenosis has led to a lower risk and improved outcome of surgical aortic valve replacement especially for women.

show abstract

Guidelines for Reporting Mortality and Morbidity After Cardiac Valve Interventions

Cited by 467 publications

References 23 publications

Valve-sparing aortic root replacement—midterm outcomes and quality of life

Valve-sparing aortic root replacement—midterm outcomes and quality of life

Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal

Risk and Outcome of Aortic Valve Surgery in the Transcatheter Valve Era: The Gender Aspect

Contact Info

Product

Resources

About